San Luis Obispo, CA, United States of America

Eden Deer Heinemann


Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1994-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eden Deer Heinemann

Introduction

Eden Deer Heinemann is a prominent inventor based in San Luis Obispo, California. She has made significant contributions to the field of biological studies, particularly in the area of neuronal nicotinic acetylcholine receptors. With a total of four patents to her name, her work has implications for understanding and potentially treating various neurological conditions.

Latest Patents

Heinemann's latest patents focus on neuronal nicotinic acetylcholine receptor compositions. These inventions relate to a family of receptors comprised of both neuronal agonist and non-agonist binding subunits, along with DNA sequences encoding these subunits. The novel receptor subunits include agonist binding subunits alpha2, alpha3, alpha4, and alpha5, as well as non-agonist binding subunits beta2, beta3, and beta4. Representative cDNA clones containing the DNA sequences of her inventions have been deposited with the American Type Culture Collection for patent purposes.

Career Highlights

Eden Deer Heinemann is affiliated with the Salk Institute for Biological Studies, where she conducts her research. Her work has garnered attention for its innovative approach to understanding the complexities of neuronal receptors and their functions.

Collaborations

Heinemann has collaborated with notable colleagues, including Stephen Fox Heinemann and James Warner Patrick. These collaborations have further enriched her research and contributed to the advancement of knowledge in her field.

Conclusion

Eden Deer Heinemann's contributions to the field of biological studies through her innovative patents highlight her role as a leading inventor. Her work on neuronal nicotinic acetylcholine receptors is paving the way for future research and potential therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…